Browsing: Critical Care

CCA-HOT ICU.jpg
The ideal oxygenation goal in patients with acute respiratory failure in the ICU remains unclear. The HOT ICU trial seeks to provide insight.
CCA-Receptor Antagonists.jpg
While much is still left to be known about COVID-19, research has supported the theory that an excessive host inflammatory response is responsible for much of the morbidity and mortality seen by the d
CCA-Tocilizumab.jpg
Originally designed for use in rheumatoid arthritis, tocilizumab is being considered as a potential therapeutic agent to treat COVID-19.
VICTAS.jpg
Does treatment with vitamin C, thiamine, and hydrocortisone lead to an increase in the number of days alive and free of mechanical ventilation and vasopressor use? The latest EMRA Critical Care Alert
CCA-beta blockers.png
The latest EMRA Critical Care Alert examines a study that questions whether ultra-short-acting beta-blockers, such as esmolol and landiolol, reduced 28-day mortality in septic patients with persistent
CCA - Peripheral IV for Vasopressors.jpg
Two recent papers offer insight into the use of peripheral IVs to administer vasopressors. Will these studies change your practice for critically ill patients in the emergency department?
47-6 Subarachnoid Hemorrhage CT.jpg
Subarachnoid hemorrhage is a terrifying, relatively frequent cause of intracranial bleeding. It has a significant degree of morbidity and mortality - and therefore is a can't-miss diagnosis.
CCA - ECMO CPR.jpg
What is possible with highly coordinated ECMO-facilitated cardiopulmonary resuscitation? A recent study demonstrates the value of exploring interesting alternatives such as ECMO cannulation in the eme
CCA - Fluid Overload.jpg
Fluid overload has not been clearly defined in the critical care arena. In situations where patients have renal, cardiac, and pulmonary dysfunction, commonly seen in the ICU, large volume fluid therap
Deep Dive - Covid Steroids.jpg
The role of corticosteroids in severe infections, sepsis and ARDS has been a constantly evolving discussion and remains controversial. The recent APROCCHSs, ADRENAL and DEXA-ARDS along with other prio